Compare Definium Therapeutics Inc. Common Shares (DFTX) vs JetBlue Airways Corporation (JBLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs JetBlue Airways Corporation — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while JetBlue Airways Corporation trades at $3.91 (market cap $1.50B). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 3.1× JetBlue Airways Corporation's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and JetBlue Airways Corporation for 44 Days on average.
| DFTX | JBLU | |
|---|---|---|
Market Cap | $4.71B | $1.50B |
Volume | 1,966,636 | 22,018,927 |
Sector | Health | Industrials |
52-Week High | $48.45 | $6.46 |
52-Week Low | $10.68 | $3.92 |
Typical Hold Time | 0 Days | 44 Days |
Enterprise Value | $3.67B | $8.86B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JetBlue (JBLU) trades at $3.92, down 2.73% on the day, reflecting ongoing challenges. The stock shows a bearish technical trend with key indicators mixed, while fundamentals reveal persistent losses with a negative net income margin of -9.32% and elevated debt levels. Recent news includes route expansion to Colombia but also capacity cuts due to fuel costs, highlighting operational pressures amid a difficult industry environment.
The outlook remains cautious with high debt and consistent earnings misses posing significant risks. However, the consensus price target of $5.89 suggests potential upside if operational improvements materialize. Investors face headwinds from fuel price volatility and competitive pressures, requiring careful monitoring of cost management and travel demand recovery for any sustained rebound.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →
